Phibro Animal Health: Bendheim proposes 486-share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Phibro Animal Health Corp. (PAHC) officer and director Daniel M. Bendheim reported a proposed sale of 486 Class A shares, with an approximate market value of $17,787.31 and an approximate sale date of August 4, 2026. He acquired 486 shares from the issuer through restricted stock vesting on August 3, 2026. The notice says the sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution.
Key Figures
Key Terms
Restricted Stock Vesting financial
Aggregate Market Value financial
vested equity award distribution financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.